SCHEMBL6136538

SCHEMBL6136538

N#CC1CC1c1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136536 1.00
SCHEMBL30210912 0.74
SCHEMBL8846549 0.73
Vuf-5296 SCHEMBL7784076 0.72
Vuf-5297 SCHEMBL7508989 0.72
Vuf-5296 SCHEMBL8846552 0.72
Cipralisant SCHEMBL7069804 0.70 HRH3 (0.57)
SCHEMBL8846230 0.69
SCHEMBL18998463 0.68
SCHEMBL1443461 0.68 HRH3 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313470-A4 NOVEL ALICYCLIC IMIDAZOLES AS H 3 AGENTS GLIATECH INC (US) 2005-02-16 EP claimed
US-6794405-B2 Alicyclic imidazoles as H3 agents MERCK & CO., INC. 2004-09-21 US claimed
US-20040029943-A1 Novel alicylic imidazoles as H3 agents MERCK SHARP & DOHME CORP. 2004-02-12 US claimed
EP-1313470-A1 NOVEL ALICYCLIC IMIDAZOLES AS H 3 AGENTS GLIATECH, INC. (US) 2003-05-28 EP claimed
US-20020042400-A1 Novel alicyclic imidazoles as H3 agents GLIATECH, INC. 2002-04-11 US claimed
WO-2002013821-A1 NOVEL ALICYCLIC IMIDAZOLES AS H3 AGENTS GLIATECH, INC. (US) 2002-02-21 WO claimed
US-6794405-B2 Alicyclic imidazoles as H3 agents MERCK & CO., INC. 2004-09-21 US disclosed
US-20040029943-A1 Novel alicylic imidazoles as H3 agents MERCK SHARP & DOHME CORP. 2004-02-12 US disclosed
US-20020042400-A1 Novel alicyclic imidazoles as H3 agents GLIATECH, INC. 2002-04-11 US disclosed